|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.6 EGP | -0.76% |
|
-3.70% | -17.20% |
| May. 19 | Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Ibnsina Pharma reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EGP 10,574.23 million compared to EGP 6,843.37 million a year ago. Net income was EGP 98.14 million compared to EGP 72.55 million a year ago.
Basic earnings per share from continuing operations was EGP 0.08 compared to EGP 0.06 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.20% | 55.44M | |
| -39.30% | 13.99B | |
| -32.35% | 10.67B | |
| -20.52% | 6.75B | |
| +10.09% | 6.29B | |
| -11.51% | 5.88B | |
| +75.00% | 4.96B | |
| -2.48% | 4.61B | |
| -9.20% | 3.74B | |
| -21.89% | 3.16B |
IBNSINA PHARMA 
